Aerosol Medication Use in COVID-19 Pandemic

Özet

Administration of aerolized drugs to patients diagnosed with COVID-19 leads to the risk of transmission of patient-generated infectiousaerosols to healthcare providers.While the COVID-19 pandemic is ongoing, in order to provide the best treatment for patients and atthe same time to protect healthcare providers at the highest level, it is necessary to increase access to information and pay maximumattention to preventive measures.